BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22116889)

  • 1. Reproductive medicine gets a new tool.
    Ang WX; Toh CX; Ng HH; Loh YH
    J Mol Cell Biol; 2011 Dec; 3(6):320-1. PubMed ID: 22116889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects of induced pluripotent stem cell technology in regenerative medicine.
    Zhang F; Citra F; Wang DA
    Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro models of pancreatic differentiation using embryonic stem or induced pluripotent stem cells.
    Higuchi Y; Shiraki N; Kume S
    Congenit Anom (Kyoto); 2011 Mar; 51(1):21-5. PubMed ID: 21129040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
    Anastasia L; Pelissero G; Venerando B; Tettamanti G
    Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical strategies for stem cell biology and regenerative medicine.
    Zhu S; Wei W; Ding S
    Annu Rev Biomed Eng; 2011 Aug; 13():73-90. PubMed ID: 21513460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reprogrammed induced pluripotent stem cells: how suitable could they be in reproductive medicine?
    Ensenat-Waser R; Pellicer A; Simon C
    Fertil Steril; 2009 Apr; 91(4):971-4. PubMed ID: 19200985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in cell lineage reprogramming.
    Zhou J; Yue W; Pei X
    Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of efficiency of terminal differentiation of oligodendrocytes from induced pluripotent stem cells versus embryonic stem cells in vitro.
    Tokumoto Y; Ogawa S; Nagamune T; Miyake J
    J Biosci Bioeng; 2010 Jun; 109(6):622-8. PubMed ID: 20471604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different developmental potential of pluripotent stem cells generated by different reprogramming strategies.
    Jiang J; Ding G; Lin J; Zhang M; Shi L; Lv W; Yang H; Xiao H; Pei G; Li Y; Wu J; Li J
    J Mol Cell Biol; 2011 Jun; 3(3):197-9. PubMed ID: 21624975
    [No Abstract]   [Full Text] [Related]  

  • 11. [Genetic manipulation and studying of differentiation properties of rat induced pluripotent stem cells].
    Liskovykh MA; Chuĭkin IA; Ranjan A; Popova E; Tolkunova EN; Chechik LL; Malinin AIu; Morozova AV; Mosienko V; Bader M; alenina N; Tomilin AN
    Tsitologiia; 2011; 53(12):946-51. PubMed ID: 22359953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ES and iPS cell research for cardiovascular regeneration.
    Yamashita JK
    Exp Cell Res; 2010 Oct; 316(16):2555-9. PubMed ID: 20385126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient hepatic differentiation from human iPS cells by gene transfer.
    Kawabata K; Inamura M; Mizuguchi H
    Methods Mol Biol; 2012; 826():115-24. PubMed ID: 22167644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells?
    Ronaghi M; Erceg S; Moreno-Manzano V; Stojkovic M
    Stem Cells; 2010 Jan; 28(1):93-9. PubMed ID: 19904738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differentiation of pluripotent stem cells into male germ cells: An update].
    Wang SY; Cui YG; Qin LJ
    Zhonghua Nan Ke Xue; 2017 May; 23(5):468-472. PubMed ID: 29717842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem cells: an emerging theranostics platform.
    Nelson TJ; Terzic A
    Clin Pharmacol Ther; 2011 May; 89(5):648-50. PubMed ID: 21512525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining pluripotent stem cells through quantitative proteomic analysis.
    Reiland S; Salekdeh GH; Krijgsveld J
    Expert Rev Proteomics; 2011 Feb; 8(1):29-42. PubMed ID: 21329426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human germ cell differentiation from pluripotent embryonic stem cells and induced pluripotent stem cells.
    Medrano JV; Simon C; Pera RR
    Methods Mol Biol; 2014; 1154():563-78. PubMed ID: 24782029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic differentiation of mouse embryonic stem cells and induced pluripotent stem cells during organoid formation in hollow fibers.
    Amimoto N; Mizumoto H; Nakazawa K; Ijima H; Funatsu K; Kajiwara T
    Tissue Eng Part A; 2011 Aug; 17(15-16):2071-8. PubMed ID: 21457096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic differentiation of pluripotent stem cells.
    Loya K; Eggenschwiler R; Ko K; Sgodda M; André F; Bleidissel M; Schöler HR; Cantz T
    Biol Chem; 2009 Oct; 390(10):1047-55. PubMed ID: 19642877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.